Literature DB >> 16265282

Is Bifidobacterium a more effective probiotic therapy than Lactobacillus for patients with irritable bowel syndrome?

Elizabeth Furrie1.   

Abstract

Entities:  

Year:  2005        PMID： 16265282     DOI： 10.1038/ncpgasthep0219

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  3 in total

1.  Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells.

Authors:  S L Zunt; L V Burton; L I Goldblatt; E E Dobbins; M Srinivasan
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

Review 2.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

3.  The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review.

Authors:  Charlotte Pratt; Matthew D Campbell
Journal:  Probiotics Antimicrob Proteins       Date:  2020-09       Impact factor: 4.609
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.